Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6166)
All Articles published online
|
Publishing Process of This Article
|
Nov 21, 2021 (publication date) through Jun 21, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | De Roza MA, Lamba M, Goh GBB, Lum JHM, Cheah MCC, Ngu JHJ. Immunoglobulin G in non-alcoholic steatohepatitis predicts clinical outcome: A prospective multi-centre cohort study. World J Gastroenterol 2021; 27(43): 7563-7571 [PMID: 34887649 DOI: 10.3748/wjg.v27.i43.7563] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i43/7563.htm |
| Number | Citing Articles |
| 1 |
Lorenz Balcar, David Bauer, Katharina Pomej, Tobias Meischl, Mattias Mandorfer, Thomas Reiberger, Michael Trauner, Bernhard Scheiner, Matthias Pinter, Michael Pavlides. Early changes in immunoglobulin G levels during immune checkpoint inhibitor treatment are associated with survival in hepatocellular carcinoma patients. PLOS ONE 2023; 18(4): e0282680 doi: 10.1371/journal.pone.0282680
|
| 2 |
Melissa Palmer, David E. Kleiner, Zachary Goodman, Elizabeth Brunt, Mark I. Avigan, Arie Regev, Paul H. Hayashi, James H. Lewis, Ruby Mehta, Stephen A. Harrison, Massimo Siciliano, Charles A. McWherter, Raj Vuppalanchi, Cynthia Behling, Veronica Miller, Naga Chalasani, Arun J. Sanyal. Liver biopsy for assessment of suspected drug‐induced liver injury in metabolic dysfunction‐associated steatohepatitis clinical trials: Expert consensus from the Liver Forum. Alimentary Pharmacology & Therapeutics 2024; 59(2): 201 doi: 10.1111/apt.17762
|
| 3 |
H.A. Osman, M Tag-Adeen, U.M. Abdelaal, E Elgezawy, K.A. Nasif, A Nafady. Different aspects of immunological profile in patients with Non-Alcoholic Fatty liver disease. Acta Gastro Enterologica Belgica 2024; 87(2): 274 doi: 10.51821/87.2.12205
|
| 4 |
Ao Liu, Xiaoling Deng, Shuhui Hou, Yuwen Xi, Keshu Xu. Activated Immune and Complement C3 Are Potential Contributors in MASH via Stimulating Neutrophil Extracellular Traps. Cells 2025; 14(10): 740 doi: 10.3390/cells14100740
|
| 5 |
Despoina Myoteri, Stratigoula Sakellariou, Dina G. Tiniakos. Histopathology of Autoimmune Hepatitis: An Update. Advances in Anatomic Pathology 2025; doi: 10.1097/PAP.0000000000000500
|
| 6 |
Suet-Ying Kwan, Alyssa N. Slayden, Aubrey R. Coronado, Rosamaria C. Marquez, Huiqin Chen, Peng Wei, Michelle I. Savage, Lana A. Vornik, Jennifer T. Fox, Shizuko Sei, Dong Liang, Heather L. Stevenson, Gregory K. Wilkerson, Mihai Gagea, Powel H. Brown, Laura Beretta. Treatment Strategies and Mechanisms Associated with the Prevention of NASH-Associated HCC by a Toll-like Receptor 4 Inhibitor. Cancer Prevention Research 2023; 16(1): 17 doi: 10.1158/1940-6207.CAPR-22-0332
|
| 7 |
Jürgen Borlak, Reinhard Spanel. Diclofenac Immune-Mediated Hepatitis: Identification of Innate and Adaptive Immune Responses at Clinically Relevant Doses. International Journal of Molecular Sciences 2025; 26(12): 5899 doi: 10.3390/ijms26125899
|
| 8 |
Ling Luo, Qianqian Ma, Limin Lin, Hao Wang, Junzhao Ye, Bihui Zhong, Meng-Hao Huang. Prevalence and Significance of Antinuclear Antibodies in Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/8446170
|
| 9 |
Leijing Zhu, Jing Ma, Danli Jin, Yongjian Zhang, Siyu Wu, Ajing Xu, Yingying Gu, Yarui An, Yuqing Miao. Flower-like WSe2 used as bio-matrix in ultrasensitive label-free electrochemical immunosensor for human immunoglobulin G determination. Analytical Sciences 2023; 39(8): 1391 doi: 10.1007/s44211-023-00351-3
|
| 10 |
Jingjing Jiao, Xuchen Zhang. Steatotic Liver Disease: Navigating Pathologic Features, Diagnostic Challenges, and Emerging Insights. Advances in Anatomic Pathology 2025; doi: 10.1097/PAP.0000000000000483
|
| 11 |
Xuchen Zhang, Dhanpat Jain. The many faces and pathologic diagnostic challenges of autoimmune hepatitis. Human Pathology 2023; 132: 114 doi: 10.1016/j.humpath.2022.06.019
|
| 12 |
Huige Li, Ning Xia. The multifaceted roles of B lymphocytes in metabolic dysfunction–associated steatotic liver disease. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1447391
|
| 13 |
Salvatore Pezzino, Maria Sofia, Gloria Faletra, Chiara Mazzone, Giorgia Litrico, Gaetano La Greca, Saverio Latteri. Gut–Liver Axis and Non-Alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut Microbiome. Biology 2022; 11(11): 1622 doi: 10.3390/biology11111622
|
| 14 |
Mengjun Wang, Amit G. Singal, Neehar Parikh, Yuko Kono, Jorge Marrero, Anand Mehta. A Biomarker Panel Based upon AFP, Fucosylated Kininogen and PEG-Precipitated IgG Is Highly Accurate for the Early Detection Hepatocellular Carcinoma in Patients with Cirrhosis in Phase II and Phase III Biomarker Evaluation. Cancers 2022; 14(23): 5970 doi: 10.3390/cancers14235970
|
| 15 |
Jiachen Fan, Na Li, Yanfang Lu, Huixia Cao. Identification of key genes in membranous nephropathy and non-alcoholic fatty liver disease by bioinformatics and machine learning. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1564288
|